Publications Search - Abstract View
||Influence of eye size and beam entry angle on dose to non-targeted tissues of the eye during stereotactic x-ray radiosurgery of AMD.
||Cantley JL, Hanlon J, Chell E, Lee C, Smith WC, Bolch WE
||Phys Med Biol
||2013 Oct 7
||Age-related macular degeneration is a leading cause of vision loss for the elderly population of industrialized nations. The IRayÂ® Radiotherapy System, developed by OrayaÂ® Therapeutics, Inc., is a stereotactic low-voltage irradiation system designed to treat the wet form of the disease. The IRay System uses three robotically positioned 100 kVp collimated photon beams to deliver an absorbed dose of up to 24 Gy to the macula. The present study uses the Monte Carlo radiation transport code MCNPX to assess absorbed dose to six non-targeted tissues within the eye-total lens, radiosensitive tissues of the lens, optic nerve, distal tip of the central retinal artery, non-targeted portion of the retina, and the ciliary body--all as a function of eye size and beam entry angle. The ocular axial length was ranged from 20 to 28Â mm in 2Â mm increments, with the polar entry angle of the delivery system varied from 18Â° to 34Â° in 2Â° increments. The resulting data showed insignificant variations in dose for all eye sizes. Slight variations in the dose to the optic nerve and the distal tip of the central retinal artery were noted as the polar beam angle changed. An increase in non-targeted retinal dose was noted as the entry angle increased, while the dose to the lens, sensitive volume of the lens, and ciliary body decreased as the treatment polar angle increased. Polar angles of 26Â° or greater resulted in no portion of the sensitive volume of the lens receiving an absorbed dose of 0.5Â Gy or greater. All doses to non-targeted structures reported in this study were less than accepted thresholds for post-procedure complications.